Linfomas no Hodgkin

Bibliografía 

Sanvisens-Bergé A, Trallero-Morales J, Ameijide-Sánchez A, et al. Proyecciones de la incidencia de los cánceres hematológicos en España, 2024. Sangre, 2024; 43(3); 95-105.

Bednarska K, Chowdhury R, Tobin JWD, Swain F, Keane C, Boyle S, Khanna R, Gandhi MK. Epstein-Barr virus-associated lymphomas decoded. Br J Haematol. 2024 Feb;204(2):415-433. doi: 10.1111/bjh.19255. Epub 2023 Dec 28. PMID: 38155519.

Biernat MM, Wróbel T. Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. Int J Mol Sci. 2021 Jul 9;22(14):7372. doi: 10.3390/ijms22147372. PMID: 34298992; PMCID: PMC8305669.

Clemens MW, Myckatyn TM, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, Horwitz SM, Hunt KK, Kadin ME, McCarthy CM, Miranda RN, Prince HM, Santanelli di Pompeo F, Holmes SD, Phillips LG. American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2024 Sep 1;154(3):473-483. doi: 10.1097/PRS.0000000000011370. Epub 2024 Feb 22. PMID: 38412359; PMCID: PMC11346714.

Zhou X, Zhang Q, Wang D, Xiang Z, Ruan J, Tang L. Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies. Gut Liver. 2024 Sep 15;18(5):845-856. doi: 10.5009/gnl240119. Epub 2024 Jul 2. PMID: 38953119; PMCID: PMC11391147.

Lurain K, Ramaswami R, Yarchoan R. The role of viruses in HIV-associated lymphomas. Semin Hematol. 2022 Oct;59(4):183-191. doi: 10.1053/j.seminhematol.2022.11.002. Epub 2022 Dec 1. PMID: 36805886; PMCID: PMC9971650.

Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of Non-Hodgkin's Lymphoma. Med Sci (Basel). 2021 Jan 30;9(1):5. doi: 10.3390/medsci9010005. PMID: 33573146; PMCID: PMC7930980.

Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S. PET/CT in Non-Hodgkin Lymphoma: An Update. Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14. PMID: 36522191.

Barrington SF, Trotman J. The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. Lancet Haematol. 2021 Jan;8(1):e80-e93. doi: 10.1016/S2352-3026(20)30365-3. Epub 2020 Dec 22. PMID: 33357487.

Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. Medeiros, L. Jeffrey et al.Modern Pathology, Volume 37, Issue 4, 100441

Sánchez-Beato M, Méndez M, Guirado M, Pedrosa L, Sequero S, Yanguas-Casás N, de la Cruz-Merino L, Gálvez L, Llanos M, García JF, Provencio M. A genetic profiling guideline to support diagnosis and clinical management of lymphomas. Clin Transl Oncol. 2024 May;26(5):1043-1062. doi: 10.1007/s12094-023-03307-1. Epub 2023 Sep 6. PMID: 37672206; PMCID: PMC11026206.

Alaggio, R. ∙ Amador, C. ∙ Anagnostopoulos, I. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022; 36:1720-174

de Leval L, Gaulard P, Dogan A. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas. Blood. 2024 Oct 31;144(18):1855-1872. doi: 10.1182/blood.2023021786. PMID: 38728419; PMCID: PMC11830980.

Leslie LA. Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas. Curr Treat Options Oncol. 2021 Oct 25;22(12):111. doi: 10.1007/s11864-021-00909-1. PMID: 34694508; PMCID: PMC8543415.

Sehn LH, Salles G. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021 Mar 4;384(9):842-858. doi: 10.1056/NEJMra2027612. PMID: 33657296; PMCID: PMC8377611.

Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024 May 4;403(10438):1791-1807. doi: 10.1016/S0140-6736(23)02705-8. Epub 2024 Apr 10. PMID: 38614113; PMCID: PMC12261310.

Ansell SM. Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024 Dec;99(12):2367-2378. doi: 10.1002/ajh.27470. Epub 2024 Sep 6. PMID: 39239794.

López C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, Orem J, Rochford R, Roschewski M, Siebert R. Burkitt lymphoma. Nat Rev Dis Primers. 2022 Dec 15;8(1):78. doi: 10.1038/s41572-022-00404-3. PMID: 36522349.

Iorgulescu JB, Medeiros LJ, Patel KP. Predictive and prognostic molecular biomarkers in lymphomas. Pathology. 2024 Mar;56(2):239-258. doi: 10.1016/j.pathol.2023.12.001. Epub 2023 Dec 19. PMID: 38216400.

Solal-celigny P, Roy P, Colombat P, et al. Follicullar lymphoma international prognostic index. Blood 2004;

A predictive model for aggressive non-Hodgkin´s lymphoma. The International Malignant Lymphoma Prognostic factors project. N Engl J Med 1993; 329: 987.

Conconi A, Lobetti-Bodoni C, Montoto S, et al. Life expectancy of young adults with follicular lymphoma Ann Oncol. 2015 Nov;26(11):2317-22.

Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new pronostic index for folicular lymphoma developed by the international folicular lymphoma prognostic factor Project. J Clin Oncol 2009; 27: 4555-4562.

Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, Herfarth K, Seymour JF, Jerkeman M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26. PMID: 33249059.

Ardeshna KM, Smith P, et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 2003; 362: 516.

Mac Manus, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282

Wilder RB, Jones D, et al. Long-term results with radiotherapy for stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001; 51: 1219.

Provencio M, Cruz Mora MÁ, Gómez-Codina J, et al. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group Leuk Lymphoma. 2014 Jan;55(1):51-5.

Melchardt T, Egle A, Greil R. How I treat diffuse large B-cell lymphoma. ESMO Open. 2023 Feb;8(1):100750. doi: 10.1016/j.esmoop.2022.100750. Epub 2023 Jan 10. PMID: 36634531; PMCID: PMC9843196.

Coiffier B, Lepage E et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235

12/12